The global Hemostatic Clip Device market reached USD 1.42 billion in 2024, growing ~14% year-over-year (YoY) from 2023 revenues of USD 1.25 billion. Rising prevalence of gastrointestinal disorders, increasing endoscopic procedures, and the adoption of minimally invasive surgeries are driving demand. The market is expected to grow at a compound annual growth rate (CAGR) of 12.8% from 2025 to 2033, reaching USD 4.5 billion by 2033.

Historical Market Growth (2015–2024)

The Hemostatic Clip Device market has shown consistent expansion:

  • 2015: Valued at USD 560 million, driven mainly by early adoption in GI procedures.

  • 2017: Reached USD 710 million, reflecting increasing endoscopy volumes.

  • 2018: Grew to USD 820 million, supported by advancements in minimally invasive devices.

  • 2020: Market expanded to USD 980 million, accelerated by rising chronic disease incidence.

  • 2022: Estimated at USD 1.18 billion, a ~15% CAGR from 2018.

  • 2023: Valued at USD 1.25 billion, preceding a 14% YoY growth to 2024’s USD 1.42 billion.

This trajectory highlights adoption trends in endoscopic and surgical procedures across hospitals and specialty clinics.

Year-Over-Year Market Comparisons (2021–2024)

  • 2021–2022: Market increased ~13%, supported by elective GI procedures resuming post-pandemic.

  • 2022–2023: Growth slowed slightly to ~6% due to supply chain challenges.

  • 2023–2024: Jumped 14% YoY, fueled by new device launches and broader hospital adoption.

  • Cumulative 3-Year Growth: Surpassed ~36%, demonstrating steady market expansion.

  • Average Annual Growth (2021–2024): ~11%, indicating sustainable demand.

Regional Market Insights (2024)

  • North America: Largest market with ~38% share (~USD 540 million), driven by advanced healthcare infrastructure and high endoscopy adoption.

  • Europe: Accounted for ~27% (~USD 383 million), supported by increasing minimally invasive surgical procedures.

  • Asia Pacific: Contributed ~25% (~USD 355 million), driven by rising hospital expansions and endoscopic procedure volumes.

  • Rest of World: ~10% (~USD 142 million), emerging markets in Latin America and MEA.

North America dominates in absolute revenue, while Asia Pacific is projected to achieve the highest CAGR over the forecast period.

Market Segmentation: Device Type and Application

By Device Type (2024)

  • Through-the-Scope Clips (TTS): Dominant with ~55% revenue share, preferred for gastrointestinal bleeding control.

  • Over-the-Scope Clips (OTS): ~35%, used for complex lesions and perforation closure.

  • Other Hemostatic Clip Devices: ~10%, including hybrid and specialty clips.

By Application (2024)

  • Gastrointestinal Bleeding: ~48%, the largest application segment.

  • Perforation Closure: ~21%, supporting endoscopic surgery safety.

  • Polypectomy & Endoscopic Resection: ~18%, for polyp removal and tumor excision.

  • Other Applications: ~13%, including bariatric procedures and cosmetic endoscopic uses.

End-User Analysis (2024)

  • Hospitals: ~68% of market revenue, leading adoption in GI, surgical, and specialty departments.

  • Ambulatory Surgical Centers (ASCs): ~22%, driven by outpatient minimally invasive procedures.

  • Clinics & Others: ~10%, including diagnostic centers and research institutions.

Investment and Revenue Insights

  • Global investments in Hemostatic Clip Devices reached USD 125 million in 2024, focused on R&D for advanced clip designs and bioabsorbable materials.

  • Revenue from TTS devices contributed ~55% of total, reflecting widespread use in routine endoscopic procedures.

  • Government healthcare allocations for GI procedure expansion added USD 18 million, up ~10% YoY, primarily in Europe and Asia Pacific.

Market Forecast (2025–2033)

  • 2025: Market projected at USD 1.60 billion, with YoY growth of ~12%.

  • 2026: Expected to reach USD 1.82 billion, reflecting rising elective procedure volumes.

  • 2030: Forecast to exceed USD 3.2 billion, driven by minimally invasive surgical adoption.

  • 2033: Projected at USD 4.5 billion, representing ~317% growth from 2024 at a CAGR of 12.8%.

  • Regional Growth: Asia Pacific expected to maintain the highest CAGR (~15%), while North America retains largest market share.

Drivers of Growth

  • Rising Endoscopic Procedures: Over 45 million GI endoscopies performed globally in 2024, boosting device demand.

  • Minimally Invasive Surgery Adoption: Increased by ~18% YoY, enhancing the use of hemostatic clips.

  • Bioabsorbable & Advanced Clips: Improved device safety and efficacy, increasing adoption by ~20% in 2024.

  • Chronic Disease Prevalence: GI bleeding and related disorders affected ~12% of adults globally, sustaining procedural volumes.

Challenges and Opportunities

  • Challenges: High device cost and training requirements limit adoption for ~10–12% of small clinics.

  • Opportunities: AI-assisted placement systems, hybrid clips, and emerging markets could unlock USD 820 million in incremental market value by 2033. Growth in Latin America and Middle East projected at ~13–15% CAGR.

Conclusion: Data-Driven Market Outlook

The Hemostatic Clip Device market has grown from USD 560 million in 2015 to USD 1.42 billion in 2024, driven by minimally invasive procedures and rising endoscopic volumes. With projected market size of USD 4.5 billion by 2033 at a 12.8% CAGR, regional expansion, device innovation, and hospital adoption will continue to support robust, data-backed growth. Advanced TTS and OTS clips, alongside government healthcare initiatives, ensure long-term market sustainability.

Read Full Research Study: Hemostatic Clip Device https://marketintelo.com/report/hemostatic-clip-device-market

Comments (0)
No login
Login or register to post your comment
arrow_back